CASSANO, GIOVANNI BATTISTA
 Distribuzione geografica
Continente #
NA - Nord America 11.131
EU - Europa 4.016
AS - Asia 1.509
AF - Africa 165
OC - Oceania 18
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.850
Nazione #
US - Stati Uniti d'America 10.823
IT - Italia 1.377
CN - Cina 777
SE - Svezia 699
DE - Germania 495
BG - Bulgaria 456
CA - Canada 304
TR - Turchia 277
UA - Ucraina 261
SG - Singapore 211
GB - Regno Unito 198
FI - Finlandia 182
VN - Vietnam 141
CH - Svizzera 125
SN - Senegal 106
FR - Francia 56
RU - Federazione Russa 51
HK - Hong Kong 45
CI - Costa d'Avorio 44
IN - India 34
BE - Belgio 31
GR - Grecia 24
AU - Australia 15
NL - Olanda 14
AT - Austria 13
PL - Polonia 7
BJ - Benin 6
IR - Iran 6
IE - Irlanda 5
NG - Nigeria 5
ES - Italia 4
KR - Corea 4
RO - Romania 4
BR - Brasile 3
CL - Cile 3
IL - Israele 3
MX - Messico 3
MY - Malesia 3
NZ - Nuova Zelanda 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
JP - Giappone 2
PT - Portogallo 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 16.850
Città #
Woodbridge 1.867
Fairfield 1.221
Ann Arbor 1.125
Houston 928
Chandler 827
Milan 646
Ashburn 624
Seattle 490
Sofia 456
Cambridge 436
Wilmington 427
Jacksonville 376
Ottawa 293
Izmir 273
Beijing 268
New York 261
Nanjing 195
Boardman 186
Princeton 175
Lawrence 172
Medford 166
Frankfurt am Main 143
Bern 123
Singapore 111
Dakar 106
Des Moines 88
Dearborn 79
Nanchang 74
Jüchen 66
Chicago 60
Rome 56
Dong Ket 50
Serra 47
San Diego 46
Abidjan 44
Falls Church 44
Florence 42
Hong Kong 39
Redwood City 39
Washington 38
Boulder 35
London 34
Hebei 31
Bremen 30
Brussels 30
Kunming 30
Marseille 29
Ogden 28
Dallas 27
Norwalk 27
Tianjin 27
Lancaster 25
Shenyang 25
Los Angeles 23
Changsha 20
Pune 20
Jiaxing 19
Hangzhou 16
Pisa 14
Hefei 13
Orange 13
Vienna 13
Auburn Hills 11
Lanzhou 10
Detroit 9
Maserada Sul Piave 9
Changchun 8
Genoa 8
Helsinki 8
Jinan 8
Cotonou 6
Guangzhou 6
Capannori 5
Lagos 5
Nürnberg 5
Phoenix 5
Varese 5
Groningen 4
North York 4
Paris 4
Quartu Sant'elena 4
San Antonio 4
San Francisco 4
Edinburgh 3
Fuzhou 3
Naples 3
Pontremoli 3
Redmond 3
Torino 3
Verona 3
Warsaw 3
Westminster 3
Yellow Springs 3
Amsterdam 2
Avellino 2
Bandar Seri Begawan 2
Braccagni 2
Brescia 2
Castelnuovo Rangone 2
Chehalis 2
Totale 13.412
Nome #
The role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder 218
The relationships among separation anxiety disorder, adult attachment style and agoraphobia in patients with panic disorder 211
[H-3]-ketanserin binding sites in different psychiatric disorders 179
Validity and reliability of the Structured Clinical Interview for the Trauma and Loss Spectrum (SCI-TALS). 174
Axis I and II disorders and quality of life in bariatric surgery candidates 171
Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders 165
Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse 149
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression 145
Mutation analysis of oxytocin gene in individuals with adult separation anxiety 140
A spectrum model for mood disorders: a useful approach in clinical psychiatry in search of an assessment methodology 138
Psychological and psychiatrical assessment in obese patients undergoing bariatric surgery 137
Validity and reliability of the Structured Clinical Interview for Obsessive-Compulsive Spectrum (SCI-OBS) and of the Structured Clinical Interview for Social Phobia Spectrum (SCI-SHY) 136
TREATMENT EMERGENT MANIA/HYPOMANIA IN UNIPOLAR PATIENTS 135
Measuring Mood spectrum: comparison of interview (SCI-MOODS) and self-report (MOODS-SR)instruments 135
The Spontaneous Ala147Thr Amino Acid Substitution within the Translocator Protein Influences Pregnenolone Production in Lymphomonocytes of Healthy Individuals 134
Borderline personality disorder and mood spectrum 133
Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders 132
Psychiatric disorders and lifetime Mood Spectrum Symptoms in Early and Late Onset Obesity 131
Ala147Thrsubstitution in translocator protein is associated with adult separation anxiety in patients with depression 130
Insight into illness in schizophrenia, schizoaffective disorder and mood disorders with psychotic features 129
EFFICACY AND SAFETY OF AMISULPRIDE 50 MG VERSUS PAROXETINE 20 MG IN MAJOR DEPRESSION: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY 128
CONFRONTO TRA DIVERSI STRUMENTI DI VALUTAZIONE PSICOPATOLOGICA IN PAZIENTI GRANDI OBESI CANDIDATI A CHIRURGIA BARIATRICA 128
SENSITIVITY TO CHANGE AND PREDICTIVE VALIDITY OF THE MOODS-SR QUESTIONNAIRE, LAST-MONTH VERSION 128
The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity 128
Clinical characteristics of mania, mixed mania, and bipolar depression with psychotic features. 127
The role of quetiapine in the treatment of bipolar disorder 126
Clinical correlates of depersonalization symptoms in patients with bipolar disorder 126
Platelet sulfotransferase in different psychiatric disorders 125
Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia 124
The factor structure of lifetime depressive spectrum in patients with unipolar depression 124
A multidimensional spectrum approach to post-traumatic stress disorder: comparison between the Structured Clinical Interview for Trauma and Loss Spectrum (SCI-TALS) and the Self-Report instrument (TALS-SR). 124
Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders 123
Oxytocin receptor polymorphisms and adult attachment style in patients with depression 123
Development and preliminary testing of the General 5-Spectrum Measure (GSM-V) 122
Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder 121
Distinguishing affective depersonalization from anhedonia in major depression and bipolar disorder 121
Psychotic features in borderline patients: is there a connection to mood dysregulation? 121
CATECHOL-O-METHYLTRANSFERASE GENE VARIANTS IN MOOD DISORDERS IN THE ITALIAN POPULATION 119
Catechol O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder 119
Venlafaxine in somatopsychic and autopsychic depersonalization. 118
Citalopram in refractory obsessive-compulsive disorder: an open study 118
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients. 118
Ligandi endogeni per i recettori delle benzodiazepine: nuovo approccio allo studio della biologia dell’ansia. 117
PSYCOPATHOLOGICAL ASSESSMENT OF A SAMPLE OF PATIENTS CANDIDATES FOR TRANSPLANTATION 117
Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment 116
THE STRUCTURE OF LIFETIME MANIC-HYPOMANIC SPECTRUM 116
Social anxiety spectrum: Gender differences in Italian high school students 116
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. 116
PREVALENCE AND BURDEN OF BIPOLAR DISORDERS IN EUROPEAN COUNTRIES 115
VALORE PREDITTIVO DI VARIABILI PSICOPATOLOGICHE E LORO MODIFICHE DOPO DECREMENTO PONDERALE OTTENUTO MEDIANTE INTERVENTO DI BENDAGGIO GASTRICO REGOLABILE 115
THE PANIC-AGORAPHOBIC SPECTRUM: DEVELOPMENT, DESCRIPTION AND CLINICAL SIGNIFICANCE 114
Exploration of the clinical profile of rubidium chloride in depression: a systematic open trial 113
Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders 113
Neurocognitive functioning in bulimia nervosa: the role of neuroendocrine, personality and clinical aspects 113
PRAMIPEXOLE IN TREATMENT-RESISTANT DEPRESSION: AN EXTENDED FOLLOW-UP 112
THE NEUROBIOLOGY AND CLINICAL SIGNIFICANCE OF DEPERSONALIZATION IN MOOD AND ANXIETY DISORDERS: A CRITICAL REAPPRAISAL 112
internal consistency and discriminant validity of a new instrument for assessing mood symptomatology: the structured clinical interview for mood spectrum (SCI-MOODS) 111
Rating scales for the assessment of depersonalization symptoms: a review 109
Substance use in severe mental illness: self-medication and vulnerability factors 109
Comparative response to electroconvulsive therapy in medication-resistant bipolar I patietns with depression and mixed state 109
Measuring social anxiety and obsessive-compulsive spectra: comparison of interviews and self-report instruments. 109
MULTIDIMENSIONAL ASSESSMENT OF THE PANIC-AGORAPHOBIC SPECTRUM: RELIABILITY AND VALIDITY OF THE SPANISH VERSION OF THE PAS-SR 109
Correlation between spectrum symptomatology and personality disorders in patients affected by overweight or obesity 108
FAMILY HISTORY OF PSYCHIATRIC DISORDERS AND ALCOHOL AND SUBSTANCE MISUSE IN PATIENTS WITH BIPOLAR I DISORDERS, SUBSTANCE USE DISORDER OR BOTH 108
Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders 108
Awareness of illness in patients with bipolar I disorder with or without comorbid anxiety disorders 107
Pramipexole in treatment-resistant depression: a 16-week naturalistic study 106
Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study 104
Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder 104
LO SPETTRO ANORESSICO-BULIMICO NEI DISTURBI DELLA CONDOTTA ALIMENTARE, DELL’UMORE E NEI CONTROLLI SANI 103
Intravenous citalopram in resistant OCD 103
Psycological variables as potential predictors of successful outcomes for weight loss programs followings Swedish adjustable gastric banding 103
Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version 103
mRNA expression of serotonin receptors of type 2C and 5A in human resting lymphocytes., 103
Axis I comorbidity in bipolar disorder with psychotic features 103
The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum. 103
The spectrum model: A more coherent approach to the complexity of psychiatric symptomatology 102
AWARENESS OF DISORDER AND SUICIDE RISK IN THE TREATMENT OF SCHIZOPHRENIA: RESULTS OF THE INTERNATIONAL SUICIDE PREVENTION TRIAL 102
HEALTH-RELATED QUALITY OF LIFE IN EUTHYMIC BIPOLAR DISORDER PATIENTS: DIFFERENCES BETWEEN BIPOLAR I AND II SUBTYPES 101
Mutation analysis of oxytocin gene in individuals with adult separation anxiety 101
Predictors of response among patients with panic disorder treated with medications in a naturalistic follow-up: the role of adult separation anxiety. 101
Absence of NK1 receptors in human blood lymphocytes and granulocytes 100
Evaluation of disease awareness in a sample of patients with eating disorder: a preliminary study 99
Spettro dell'umore in gravidanza e nel postpartum 99
Asymptomatic hypermylasemia and hyperlipasemia associated with aripiprazole 99
Validity and reliability of a new instrument for assessing mood symptomatology: the Structured Clinical Interview for Mood Spectrum (SCI-MOODS) 99
The Mood Spectrum Self-Report: Validation and adaptation into Spanish 99
The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms 99
Efficacy of ECT in depression: a meta-analytic review 98
Oxytocin receptor polymorphisms and adult attachment style in patients with depression 98
Bipolar disorder in late life: clinical characteristics in a sample of older adults admitted for manic episode 97
The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. 97
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide 96
Lifetime rhythmicity and mania as correlates of suicidal ideation and attempts in mood disorders. 96
null 95
Pramipexole augmentation in panic with agoraphobia 95
Gender moderates the relationship between mania spectrum and serotonin transporter polymorphisms in depression 94
The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology 93
Fluvoxamine maleate: Double-blind clinical trial vs placebo in hospitalized depressed patients 93
Panic disorder as a risk factor for post-partum depression Results from the Perinatal Depression-Research & Screening Unit (PND-ReScU) study 92
Totale 11.805
Categoria #
all - tutte 39.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.403 0 0 0 228 335 370 393 257 339 198 230 53
2020/20211.248 146 79 98 57 152 44 85 147 89 90 80 181
2021/20221.862 35 100 28 126 389 261 47 99 107 77 99 494
2022/20232.328 301 225 117 227 262 274 15 171 586 13 119 18
2023/20242.045 316 281 271 161 315 330 28 42 25 56 32 188
2024/2025272 27 184 20 41 0 0 0 0 0 0 0 0
Totale 16.995